Institutional investors hold a majority ownership of INSM through the 68.06% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $3.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERCEPTIVE ADVISORS LLC Bought 1.5 Million shares of Insmed Inc
POINT72 ASSET MANAGEMENT LP Bought 1.4 Million shares of Insmed Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.2 Million shares of Insmed Inc